India · Delayed Price · Currency is INR Chandra Bhagat Pharma Statistics
Total Valuation
BOM:542934 has a market cap or net worth of INR 331.15 million. The enterprise value is 448.43 million.
| Market Cap | 331.15M |
| Enterprise Value | 448.43M |
Important Dates
The next estimated earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:542934 has 7.55 million shares outstanding. The number of shares has decreased by -0.07% in one year.
| Current Share Class | 7.55M |
| Shares Outstanding | 7.55M |
| Shares Change (YoY) | -0.07% |
| Shares Change (QoQ) | +1.47% |
| Owned by Insiders (%) | 73.76% |
| Owned by Institutions (%) | 7.30% |
| Float | 1.30M |
Valuation Ratios
The trailing PE ratio is 10.86.
| PE Ratio | 10.86 |
| Forward PE | n/a |
| PS Ratio | 0.28 |
| PB Ratio | 1.00 |
| P/TBV Ratio | 1.00 |
| P/FCF Ratio | 3.98 |
| P/OCF Ratio | 3.59 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.28, with an EV/FCF ratio of 5.39.
| EV / Earnings | 14.72 |
| EV / Sales | 0.39 |
| EV / EBITDA | 6.28 |
| EV / EBIT | 7.34 |
| EV / FCF | 5.39 |
Financial Position
The company has a current ratio of 1.50, with a Debt / Equity ratio of 0.50.
| Current Ratio | 1.50 |
| Quick Ratio | 1.02 |
| Debt / Equity | 0.50 |
| Debt / EBITDA | 2.31 |
| Debt / FCF | 1.99 |
| Interest Coverage | 3.05 |
Financial Efficiency
Return on equity (ROE) is 9.66% and return on invested capital (ROIC) is 10.11%.
| Return on Equity (ROE) | 9.66% |
| Return on Assets (ROA) | 3.90% |
| Return on Invested Capital (ROIC) | 10.11% |
| Return on Capital Employed (ROCE) | 17.10% |
| Weighted Average Cost of Capital (WACC) | 5.23% |
| Revenue Per Employee | 29.07M |
| Profits Per Employee | 761,525 |
| Employee Count | 40 |
| Asset Turnover | 1.19 |
| Inventory Turnover | 34.89 |
Taxes
In the past 12 months, BOM:542934 has paid 10.59 million in taxes.
| Income Tax | 10.59M |
| Effective Tax Rate | 25.80% |
Stock Price Statistics
The stock price has decreased by -27.93% in the last 52 weeks. The beta is -0.16, so BOM:542934's price volatility has been lower than the market average.
| Beta (5Y) | -0.16 |
| 52-Week Price Change | -27.93% |
| 50-Day Moving Average | 38.40 |
| 200-Day Moving Average | 56.61 |
| Relative Strength Index (RSI) | 58.01 |
| Average Volume (20 Days) | 14,250 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:542934 had revenue of INR 1.16 billion and earned 30.46 million in profits. Earnings per share was 4.04.
| Revenue | 1.16B |
| Gross Profit | 227.09M |
| Operating Income | 61.08M |
| Pretax Income | 41.05M |
| Net Income | 30.46M |
| EBITDA | 71.37M |
| EBIT | 61.08M |
| Earnings Per Share (EPS) | 4.04 |
Balance Sheet
The company has 47.79 million in cash and 165.07 million in debt, with a net cash position of -117.28 million or -15.54 per share.
| Cash & Cash Equivalents | 47.79M |
| Total Debt | 165.07M |
| Net Cash | -117.28M |
| Net Cash Per Share | -15.54 |
| Equity (Book Value) | 331.27M |
| Book Value Per Share | 43.62 |
| Working Capital | 291.87M |
Cash Flow
In the last 12 months, operating cash flow was 92.36 million and capital expenditures -9.21 million, giving a free cash flow of 83.15 million.
| Operating Cash Flow | 92.36M |
| Capital Expenditures | -9.21M |
| Depreciation & Amortization | 10.30M |
| Net Borrowing | -43.53M |
| Free Cash Flow | 83.15M |
| FCF Per Share | 11.02 |
Margins
Gross margin is 19.53%, with operating and profit margins of 5.25% and 2.62%.
| Gross Margin | 19.53% |
| Operating Margin | 5.25% |
| Pretax Margin | 3.53% |
| Profit Margin | 2.62% |
| EBITDA Margin | 6.14% |
| EBIT Margin | 5.25% |
| FCF Margin | 7.15% |
Dividends & Yields
BOM:542934 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.07% |
| Shareholder Yield | 0.07% |
| Earnings Yield | 9.20% |
| FCF Yield | 25.11% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |